Facets (new session)
Description
Metadata
Settings
owl:sameAs
Inference Rule:
asEquivalent
b3s
b3sifp
facets
http://www.w3.org/2002/07/owl#
ldp
oplweb
skos-trans
virtrdf-label
virtrdf-url
None
About:
Erlotinib (Tarceva) in patients with advanced non-small lung cancer (NSCLC)-The single institution experience
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
http://linked.opendata.cz/ontology/domain/vavai/Vysledek
, within Data Space :
linked.opendata.cz
associated with source
document(s)
Type:
skos:Concept
http://linked.opendata.cz/ontology/domain/vavai/Vysledek
New Facet based on Instances of this Class
Attributes
Values
rdf:type
skos:Concept
http://linked.opendata.cz/ontology/domain/vavai/Vysledek
Description
A single-instution experience is presented of Erlotinib (Tarceva) used to treat patients with advanced non-small lung cancer (NSCLC).
A single-instution experience is presented of Erlotinib (Tarceva) used to treat patients with advanced non-small lung cancer (NSCLC).
(en)
Title
Erlotinib (Tarceva) in patients with advanced non-small lung cancer (NSCLC)-The single institution experience
Erlotinib (Tarceva) in patients with advanced non-small lung cancer (NSCLC)-The single institution experience
(en)
skos:prefLabel
Erlotinib (Tarceva) in patients with advanced non-small lung cancer (NSCLC)-The single institution experience
Erlotinib (Tarceva) in patients with advanced non-small lung cancer (NSCLC)-The single institution experience
(en)
skos:notation
RIV/00216224:14110/08:00033463!RIV10-MSM-14110___
http://linked.open...avai/riv/aktivita
Z
http://linked.open...avai/riv/aktivity
Z(MSM 141100003)
http://linked.open...iv/cisloPeriodika
4
http://linked.open...vai/riv/dodaniDat
2010
http://linked.open...aciTvurceVysledku
Skřičková, Jana
Tomíšková, Marcela
http://linked.open.../riv/druhVysledku
J - Článek v odborném periodiku
http://linked.open...iv/duvernostUdaju
S - Úplné a pravdivé údaje nepodléhající ochraně podle zvláštních právních předpisů
http://linked.open...titaPredkladatele
Masarykova univerzita / Lékařská fakulta
http://linked.open...dnocenehoVysledku
366455
http://linked.open...ai/riv/idVysledku
RIV/00216224:14110/08:00033463
http://linked.open...riv/jazykVysledku
eng - angličtina
http://linked.open.../riv/klicovaSlova
non-small cell lung cancer; advanced cancer; treatmetment; erlotinib
(en)
http://linked.open.../riv/klicoveSlovo
advanced cancer
non-small cell lung cancer
erlotinib
treatmetment
http://linked.open...odStatuVydavatele
CH - Švýcarská konfederace
http://linked.open...ontrolniKodProRIV
[0DD1BF28EF94]
http://linked.open...i/riv/nazevZdroje
Journal of Thoracic Oncology
http://linked.open...in/vavai/riv/obor
FC
http://linked.open...ichTvurcuVysledku
2
(
xsd:int
)
http://linked.open...cetTvurcuVysledku
3
(
xsd:int
)
http://linked.open...UplatneniVysledku
2008
http://linked.open...v/svazekPeriodika
3
http://linked.open...iv/tvurceVysledku
Skřičková, Jana
Tomíšková, Marcela
Vašutová, Irena
http://linked.open...n/vavai/riv/zamer
http://linked.opendata.cz/resource/domain/vavai/zamer/MSM%20141100003
issn
1556-0864
number of pages
3
(
xsd:int
)
http://localhost/t...ganizacniJednotka
14110
is
http://linked.open...avai/riv/vysledek
of
Erlotinib (Tarceva) in patients with advanced non-small lung cancer (NSCLC)-The single institution experience
Erlotinib (Tarceva) in patients with advanced non-small lung cancer (NSCLC)-The single institution experience
Erlotinib (Tarceva) in patients with advanced non-small lung cancer (NSCLC)-The single institution experience
Erlotinib (Tarceva) in patients with advanced non-small lung cancer (NSCLC)-The single institution experience
Faceted Search & Find service v1.16.118 as of Jun 21 2024
Alternative Linked Data Documents:
ODE
Content Formats:
RDF
ODATA
Microdata
About
OpenLink Virtuoso
version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 58 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software